PCK2 inhibits lung adenocarcinoma tumor cell immune escape through oxidative stress-induced senescence as a potential therapeutic target

BACKGROUND: Our research aimed to better understand how phosphoenolpyruvate carboxykinase 2 (PCK2) is linked to survival outcomes in lung cancer patients. METHODS: We confirmed PCK2 expression and its association with the outcome of lung cancer patients using The Cancer Genome Atlas (TCGA) database....

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mingming, Sun, Jianjun, Cai, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267946/
https://www.ncbi.nlm.nih.gov/pubmed/37324064
http://dx.doi.org/10.21037/jtd-23-542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267946/
https://www.ncbi.nlm.nih.gov/pubmed/37324064
http://dx.doi.org/10.21037/jtd-23-542

Ejemplares similares